The Shortfalls Of Biological Indicators For HPV Decontamination Validation

The Vapour phase hydrogen peroxide (VPHP) process that is used for decontamination validation, conventionally uses Biological Indicators (BIs) to confirm decontamination has been achieved.  This translates into a lengthy process (which can take up to weeks or even months) with highly detailed protocols to be executed that we believe are highly un-optimised, costly and risky.…

Enzyme Indicators Proven As Viable Alternative For HPV Decontamination Validation

Enzyme Indicators (EI’s) have been proven as a revolutionary viable alternative to biological indicators (BI’s) for Hydrogen Peroxide decontamination validation. A white paper published today by the Parenteral Drug Association (PDA) Journal of Pharmaceutical Science & Technology, and written by Public Health England (PHE), states that Enzyme Indicators are a “potentially valuable tool for rapid…

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…